Cancer Family
Carcinoma
CI-CAN-00000114Explore in graph →
7,369 active trials118 approved drugs1,149 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000114Explore in graph →
Clinical trials
25,729 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (3,405)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00034957 | Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | — | PfizerINDUSTRY | 1 | Feb 16, 2012 | clinicaltrials |
| NCT00913198 | A Study of CP-4126 in Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 21 | Clavis PharmaINDUSTRY | 2 | Feb 10, 2012 | clinicaltrials |
| NCT01270386 |
| A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer |
| completed |
| Phase 2 |
| 136 |
| Jiangsu HengRui Medicine Co., Ltd.INDUSTRY |
| 1 |
| Feb 10, 2012 |
| clinicaltrials |
| NCT00578214 | Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery | completed | N/A | 75 | Mayo ClinicOTHER | 1 | Feb 9, 2012 | clinicaltrials |
| NCT00176774 | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma | completed | Phase 2 | 24 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00138658 | A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 85 | Achieve Life SciencesINDUSTRY | 2 | Feb 6, 2012 | clinicaltrials |
| NCT00474825 | Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of the Head and Neck(HBO-XRT) | completed | Phase 1 | 12 | National Baromedical ServicesOTHER | 1 | Feb 6, 2012 | clinicaltrials |
| NCT00777699 | Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors | completed | Phase 1 | 80 | SanofiINDUSTRY | 1 | Feb 3, 2012 | clinicaltrials |
| NCT01088581 | Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma | completed | Phase 3 | 101 | Yonsei UniversityOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01131689 | Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma | completed | Phase 1 | 20 | Samsung Medical CenterOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01031784 | Radioactive Holmium Microspheres for the Treatment of Liver Metastases(HEPAR) | completed | Phase 1 | 15 | UMC UtrechtOTHER | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00714025 | A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy | completed | Phase 2 | 40 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Jan 24, 2012 | clinicaltrials |
| NCT00408226 | Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 27 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT01260038 | Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium.(HERMES) | completed | — | 107 | University Hospital, AntwerpOTHER | 1 | Jan 18, 2012 | clinicaltrials |
| NCT01510002 | Prophylactic Central Neck Dissection for Papillary Thyroid Cancer | completed | N/A | 640 | Jagiellonian UniversityOTHER | 1 | Jan 13, 2012 | clinicaltrials |
| NCT01508546 | Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer | completed | Phase 3 | 565 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT01083589 | Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 22 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 11, 2012 | clinicaltrials |
| NCT01223209 | A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma | completed | Phase 1 | 12 | Lytix Biopharma ASINDUSTRY | 1 | Jan 11, 2012 | clinicaltrials |
| NCT01065415 | Whole-Body Magnetic Resonance Imaging/Positron Emission Tomography (MRI/PET) in the Staging of Non-Small-Cell Lung Cancer (NSCLC) | completed | — | 272 | Samsung Medical CenterOTHER | 1 | Dec 29, 2011 | clinicaltrials |
| NCT00606021 | A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 2 | 106 | Eli Lilly and CompanyINDUSTRY | 3 | Dec 26, 2011 | clinicaltrials |
| NCT00721175 | Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma | completed | Phase 4 | 108 | Khon Kaen UniversityOTHER | 1 | Dec 23, 2011 | clinicaltrials |
| NCT01126060 | Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain | completed | Phase 3 | 78 | Samsung Medical CenterOTHER | 1 | Dec 19, 2011 | clinicaltrials |
| NCT01494558 | Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 200 | Chinese Academy of Medical SciencesOTHER | 0 | Dec 19, 2011 | clinicaltrials |
| NCT01355107 | Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease | completed | — | 32 | University Hospital FreiburgOTHER | 1 | Dec 14, 2011 | clinicaltrials |
| NCT00006379 | Non-Ablative Allo HSCT For Hematologic Malignancies or SAA | completed | Phase 2 | 58 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 8, 2011 | clinicaltrials |
| NCT00006253 | Pain and Fatigue Study | completed | N/A | 350 | Michigan State UniversityOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00799084 | Automated Telephone Monitoring for Symptom Management(ATSM) | completed | Phase 2 | 526 | Michigan State UniversityOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00970983 | Axillary Dissection Based on the Histological Result of the Sentinel Node, in Patients With Breast Carcinoma | completed | N/A | 532 | European Institute of OncologyOTHER | 1 | Nov 29, 2011 | clinicaltrials |
| NCT01222312 | Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel(Taxelox) | completed | Phase 2 | 88 | Krankenhaus NordwestOTHER | 1 | Nov 29, 2011 | clinicaltrials |
| NCT00197860 | Dendritic Cell Based Therapy of Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 40 | Inge Marie SvaneOTHER | 1 | Nov 23, 2011 | clinicaltrials |
| NCT00280852 | Review of Multimodality Management of Anaplastic Thyroid Cancer | completed | — | 5 | Alberta Health servicesOTHER | 1 | Nov 21, 2011 | clinicaltrials |
| NCT00136864 | Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial) | completed | Phase 3 | 310 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Nov 18, 2011 | clinicaltrials |
| NCT00298545 | Effect of Vitamin D and Calcium on Genes in the Colon | completed | Phase 1 | 10 | Rockefeller UniversityOTHER | 1 | Nov 18, 2011 | clinicaltrials |
| NCT00927043 | Study Evaluating Renal Cell Carcinoma Risk Factors(MICRA) | completed | — | 145 | PfizerINDUSTRY | 1 | Nov 7, 2011 | clinicaltrials |
| NCT01246843 | Evaluation of Cognitive Function of Patients With Sunitinib or Sorafenib | completed | — | 50 | Radboud University Medical CenterOTHER | 1 | Nov 2, 2011 | clinicaltrials |
| NCT00051571 | Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma | completed | Phase 2 | 60 | Seagen Inc.INDUSTRY | 1 | Oct 24, 2011 | clinicaltrials |
| NCT00086333 | FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma | completed | Phase 2 | 30 | Seagen Inc.INDUSTRY | 1 | Oct 24, 2011 | clinicaltrials |
| NCT00191308 | Molecular Profiling in Lung Cancer Patients | completed | Phase 2 | 30 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 21, 2011 | clinicaltrials |
| NCT00046787 | Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer | completed | Phase 2 | 47 | Astellas Pharma IncINDUSTRY | 2 | Oct 20, 2011 | clinicaltrials |
| NCT00072618 | Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients | completed | Phase 1 / Phase 2 | 52 | Astellas Pharma IncINDUSTRY | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00085826 | A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients | completed | Phase 3 | 600 | Astellas Pharma IncINDUSTRY | 1 | Oct 20, 2011 | clinicaltrials |
| NCT01173445 | Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma | completed | — | 19 | University of KansasOTHER | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00036036 | Study of CP-461 in Patients With Advanced Renal Cell Cancer | completed | Phase 2 | 14 | Astellas Pharma IncINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00356122 | Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 53 | SanofiINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00519688 | UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma | completed | Phase 2 | 44 | National Taiwan University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer(CORGI) | completed | Phase 1 / Phase 2 | 106 | Lund University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00451880 | Study of XL281 in Adults With Solid Tumors | completed | Phase 1 | 180 | ExelixisINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT01103089 | Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP) | completed | — | 10 | AstraZenecaINDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT01449942 | Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma(NPC-DZ) | completed | Phase 1 / Phase 2 | 40 | Xiangya Hospital of Central South UniversityOTHER | 1 | Oct 10, 2011 | clinicaltrials |
| NCT00563147 | A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma | completed | Phase 1 | 28 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 4, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Feb 16, 2012source: clinicaltrials